Economic evidence in decision-making process in laboratory medicine

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 4, 2011, Pages 617-621

  Brunetti, Massimo ^a   Pregno, Silvia ^b   Schünemann, Holger ^c   Plebani, Mario ^d   Trenti, Tommaso ^a  

^a Nuovo Ospedale S Agostino   (Italy)

^b Public Health Physicians Modena   (Italy)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

appropriateness; costs; economic evidence; guidelines; laboratory medicine; recommendations

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ACUTE DISEASE; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DYSPNEA; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HEART FAILURE; HUMAN; MEDICAL DECISION MAKING; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS;

CLINICAL LABORATORY TECHNIQUES; DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; PUBLIC HEALTH;

EID: 79954524889     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.119     Document Type: Article

References (41)

1. Guidi GC, Lippi G Laboratory medicine in the 2000s: pro-grammed dead or rebirth? Clin Chem Lab Med 2006;44:913-7.
2. Plebani M. Laboratory diagnostic in the third millennium: where, how and why? Clin Chem Lab Med 2010;48:901-2.
3. Bossuyt X, Verweire K, Blanckaert N. Laboratory medicine: challenges and opportunities. Clin Chem 2007;53:1730-3. (Pubitemid 47509664)
4. Plebani M. The future of clinical laboratories: more testing or knowledge services? Clin Chem Lab Med 2005;43:893-6. (Pubitemid 41461135)
5. Langlois MR, Wallemacq P. The future of hospital laboratories. Position statement from the Royal Belgian Society of Clinical Chemistry (RBSCC). Clin Chem Lab Med 2009;47:1195-201.
6. Plebani M. Laboratory medicine: value for patients is the goal. Clin Chem 2007;53:1873-4. (Pubitemid 47509690)
7. Mugford M, Shemilts I, Vale L, Marsh K, Donaldson C, Mal-lender J. From effectiveness to efficiency? An introduction to evidence-based decisions and economics. In: Shemilt I, Mug-ford M, Vale L, Marsh K, Donaldson C, editors. Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice. Oxford: Wiley-Blackwell, 2010.
8. Higgins JP, Green S (editors). Cochrane Handbook for System-atic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
9. Trenti T Evidence-based laboratory medicine as a tool for con-tinuous professional improvement. Clin Chim Acta 2003;333: 155-67. (Pubitemid 36773965)
10. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, De-Cristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-45. (Pubitemid 36741592)
11. Christenson RH. Evidence-based laboratory medicine-a guide for critical evaluation of in vitro laboratory testing. Ann Clin Biochem 2007;44:111-30. (Pubitemid 46525007)
12. Trenti T Clinical governance and evidence based laboratory medicine. Clin Chem Lab Med 2006;44:724-32. (Pubitemid 43832868)
13. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stod-dard GL. Methods for the economic evaluation of health care programmes, 3rd ed. Oxford: Oxford University Press, 2005.
14. Eddama O, Coast J. A systematic review to the use of economic evaluation in local decision-making. Health Policy 2008;86: 129-41.
15. Van Velden ME, Severens JL, Novak A. Economic evaluations of health care programmes and decision-making: the influence of economic evaluations on different health care decision-mak-ing levels. Pharmacoeconomics 2005;23:1075-82. (Pubitemid 41633400)
16. Williams I, McIver S, Moore D, Byran S. The use of economic evaluations in NHS decision-making: a review and empirical investigation. Health Technology Assessment 2008;12:iii, ix-x, 1-175.
17. Eddama O, Coast J. Use of economic evaluation in local health care decision-making in England: a qualitative investigation. Health Policy 2009;89:261-70.
18. Coast J. Is economic evaluation in touch with society's health values? Br Med J 2004;329:1233-6. (Pubitemid 39551449)
19. Barth JH, Seth J, Howlett TA, Freedman DB. A survey of endo-crine function testing by clinical biochemistry laboratories in the UK. Ann Clin Biochem 1995;32:442-9.
20. Miyakis S, Karamanof G, Liontos M, Mountokalakis TD. Factors contributing to inappropriate ordering of tests in an aca-demic medical department and the effect of an educational feedback strategy Postgrad Med J 2006;82:823-9. (Pubitemid 46101932)
21. van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory Clinical audits. J Am Med Assoc 1998;280:550-8. (Pubitemid 28377676)
22. Winkens R, Dinant GJ. Evidence base of clinical diagnosis: rational, cost effective use of investigations in clinical practice. Br Med J 2002;324:783.
23. Field MJ, Lohr KN, editors. 'Guidelines for clinical practice: from development to use'. Institute of Medicine, Washington, 1992.
24. Eccles M, Mason J. How to develop cost-conscious guidelines. Health Technology Assessment 2001;5:N. 16.
25. Jessup M, Abraham WT, Casey DE, et al. 2009 Focused Update: ACCF/AHA guidelines for the diagnosis and manage-ment of heart failure in adults: a report of the ACCF American College of Cardiology Foundation/American Heart Association Task Force on Practice guidelines developed in collaboration with the International Society for Heart and Lung Transplan-tation. J Am Coll Cardiol 2009;53:1343-82
26. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardi-ology ESC guidelines for the Diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-442.
27. Arnold JM, Howlett JG, Dorian P, Ducharme A, Giannetti N, Haddad H, et al. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: pre-vention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol 2007;23:21-45. (Pubitemid 46403407)
28. Reinhold T, Berghöfer A, Willich SN. Is the determination of biomarkers worth its price? Review of the literature taking brain natriuretic peptides (BNP) as an example. Herz 2010;35: 1-10.
29. Mueller C, Laule-Kilian K, Schindler C, Klima T, Frana B, Rodriguez D, et al. Cost-effectiveness of B-type natriuretic pep-tide testing in patients with acute dyspnea. Arch Intern Med 2006;166:1081-7. (Pubitemid 43765179)
30. Breidthardt T, Laule K, Strohmeyer AH, et al. Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea. Clin Chem 2007;53;8:1415-22. (Pubitemid 47206337)
31. Schünemann HJ, Best D, Vist G, Oxman AD. For the GRADE Working Group. Letters, numbers, symbols, and words: how best to communicate grades of evidence and recommendations? Can Med Assoc J (CMAJ) 2003;169:677-80. (Pubitemid 37266979)
32. GRADE Working Group. Grading quality of evidence and strength of recommendations. Br Med J 2004;328:1490.
33. Ibargoyen-Roteta N, Gutiérrez-Ibarluzea I, Rico-Iturrioz R, López-Argumedo M, Reviriego-Rodrigo E, Cabriada-Nuño JL, et al. The GRADE approach for assessing new technologies as applied to apheresis devices in ulcerative colitis. Implement Sci 2010;16:48.
34. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alon-so-Coello P, et al. For the GRADE Working Group GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 2008;336:924-6. (Pubitemid 351632017)
35. Schünemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. Br Med J 2008;336:1106-10. (Pubitemid 351731739)
36. Brunetti M, Ruiz F, Lord J, et al. Grading economic evidence. In: Shemilt I, Mugford M, Vale L, Marsh K, Donaldson C, editors. Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice. Oxford: Wiley-Blackwell, 2010.
37. Guyatt GH, Oxman AD, Kunz R, et al. For the GRADE Work-ing Group GRADE: going from evidence to recommendations. Br Med J 2008;336:1049-51. (Pubitemid 351692246)
38. Brunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, Lord J, et al. GRADE guidelines: 11. Special challenges-quality of evidence for resource use. J Clin Epidem In press.
39. Elixhauser A, Halpern M, Schmier J, Luce BR. Health care CBA and CEA from 1991 to 1996: an updated bibliography Med Care 1998;36(Suppl 5):MS1-9, MS18-147
40. Tan-Torres Edejer T Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications. Health Research Policy and Systems 2006;4:23.
41. Elshaug AG, Hiller JE, Moss JR. Exploring policy-makers' per-spectives on disinvestment from ineffective healthcare practic-es. Int J Technol Assess Health Care 2008;24:1-9. (Pubitemid 351158537)